Agenda
| 5:50 pm | Welcome and Opening Remarks Dr. Lawrence Leiter |
| 6:00 pm | The latest from diabetes CVOTs with SGLT2 inhibitors Dr. Lawrence Leiter |
| 6:15 pm | DAPA-HF and the prevention of diabetes Dr. Subodh Verma |
| 6:30 pm | Clinical implications of REDUCE-IT in diabetes Dr. Deepak L. Bhatt |
| 6:45 pm | What’s new from the CREDENCE study and what are the implications to managing patients with diabetic kidney disease? Dr. Vlado Perkovic |
| 7:00 pm | Q & A Dr. Vlado Perkovic |
| 7:30 pm | Closing Remarks Dr. Lawrence A. Leiter |
Faculty
Dr. Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
CHAIR
Endocrinologist,
St. Michael’s Hospital;
Professor of Medicine and Nutritional
Sciences, University of Toronto,
Toronto, ON
Deepak L. Bhatt
MD, MPH, FACC, FAHA, FSCAI, FESC
Cardiologist, Executive Director of
Interventional Cardiovascular Programs,
Brigham and Women’s Hospital
Heart & Vascular Center;
Professor of Medicine,
Harvard Medical School,
Boston, MA
Vlado Perkovic
MBBS, PhD, FRACP, FASN, FAHMS
Dean of Medicine and Scientia Professor,
UNSW; Professorial Fellow, The George
Institute; Staff Specialist in Nephrology,
Royal North Shore Hospital,
Sydney, NSW, Australia
Dr. Subodh Verma
MD, PhD, FRCSC, FAHA
Cardiac Surgeon, St. Michael’s Hospital;
Professor of Surgery and Pharmacology &
Toxicology, University of Toronto;
Canada Research Chair in Cardiovascular
Surgery, Toronto, ON
Video Information
- Credit:No Credit Available
- Post Date:July 13, 2020
- Expiry Date:N/A
